Contents Table for Abstracts and Electronical Slide Presentation
PREFACE
GLOBAL HARMONIZATION
Global Harmonization and the Achievements of ICH
Dr. Elaine C. Esber (U.S. Food and Drug Administration)Impact of ICH Prosess and Guidelines
Dr. Keiji Ueda (Tokyo Metropolitan Tama Geriatric Hospital,The Organization for Pharmaceutical Safety and Research)
|
|
ETHNIC DIFFERENCES
Drug Metabolism
Disease Presentation West vs East
Cardiovascular Disease in Asia: Mortality and Risk Factors Dr. Jiang He (Tulane University)
|
Dose Setting
Significance of Dose Setting Studies in the Bridging Study Strategy Dr. Chikayuki Naito (Tokyo Teishin Hospital,The Organization for Pharmaceutical Safety and Research)
|
|
BRIDGING STRATEGIES
Bridging : Efficacy and Safety
Bridging : Methods and Special Populations
Bridging: Statistical Considerations
Statistical Issues on Bridging Studies Prof. Masahiro Takeuchi (Kitasato University Graduate School)
Methodological Issues in Evaluation of Bridging Evidence for Pharmaceutical Products
Prof. Jen-Pei Liu (National Health Reseach Institutes, Taiwan)
|
Bridging Guidance
|
FUTURE STRATEGIES AND CHALLENGES
Bridging Western Data to Japan
Bridging Japanese Data to the West
Depression: Western and Japanese Differences
|
|